Drugs / Piperacillin/tazobactam
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03560232 Comparator | Jul 2018 → Feb 2020 | — | Mercy Health Ohio | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Piperacillin/tazobactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03560232 ↗ |
| Route | Intravenous | “Piperacillin/Tazobactam 3.375g IV every 8 hours over 4 hours” NCT03560232 ↗ |